SCHEDULE 13G

Company

Cardiff Oncology, Inc.

Filed

December 26, 2017

Accession Number

0001213900-17-013637

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →